Which patents cover Angiovist 282, and what substitute generic drugs are available?Angiovist 282 is a drug marketed by Bayer Hlthcare and is included in one NDA.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|INJECTABLE;INJECTION||087726-001||Sep 23, 1982||DISCN||No||No||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.